US Broker Ratings

Bruker Corporation (BRKR) Stock Report: Assessing the 8.83% Potential Upside for Investors

Bruker Corporation (NASDAQ: BRKR) is a key player in the healthcare sector, specifically within the medical devices industry, offering a rich portfolio of scientific instruments and analytical solutions. Headquartered in..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Innovator with 138% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector, presenting a compelling opportunity for investors with a notable potential upside of 138.22%. With its innovative approach to..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 14% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a distinguished player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.23 billion, Bio-Rad is a..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Market with 7.84% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands at the crossroads of innovation and opportunity within the healthcare sector, with its latest stock analysis revealing a potential upside of 7.84%. As a key..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with Steady Growth

As an investor in the healthcare sector, understanding the dynamics of companies like Henry Schein, Inc. (NASDAQ: HSIC) is crucial for building a diversified portfolio. With a market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 31.93% Potential Upside

Encompass Health Corporation (NYSE: EHC) has captured the attention of investors with its robust growth prospects and substantial potential upside. Operating in the healthcare sector, EHC specializes in providing post-acute..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 19% Potential Upside in the Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, is increasingly capturing investor attention with its innovative approach to drug discovery and development. The company, which has carved a..

Revvity, Inc. (RVTY) Stock Analysis: Potential 16.53% Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling opportunity for investors seeking to capitalize on its position..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 13% Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.79 billion, the company has..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Innovation and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) remains a pivotal player in the healthcare sector, particularly within diagnostics and research. With a market capitalization of $9.96 billion, Charles River is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a Promising 10.64% Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market capitalization of $15.08 billion, the company stands out..

Quest Diagnostics (DGX) Stock Analysis: Potential 13.97% Upside Captures Investor Attention

Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the healthcare sector, stands out with a market capitalization of $19.43 billion. This diagnostic and research titan, headquartered in Secaucus, New..

Exact Sciences Corporation (EXAS) Stock Analysis: Unveiling Growth Potential in Cancer Diagnostics

Exact Sciences Corporation (NASDAQ: EXAS), a pivotal player in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening solutions. With a robust..

Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the life sciences sector, is capturing investor attention with its promising growth trajectory and a potential upside of 15.13%. Based in Waltham,..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential Upside Amid Solid Performance Metrics

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, operates an extensive network of acute care and behavioral health facilities across the United States. With a..

Abbott Laboratories (ABT) Stock Analysis: Exploring the 16.52% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leader in the medical..

Gilead Sciences (GILD) Stock Analysis: Key Insights on Growth, Dividends, and Analyst Ratings

Gilead Sciences, Inc. (GILD) stands as a prominent player in the healthcare sector, primarily focused on the drug manufacturing industry. With a market capitalization of $150.88 billion, Gilead has earned..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 23% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), headquartered in Dublin, Ireland, is a prominent player in the biotechnology sector, renowned for its innovative drug portfolio aimed at addressing diverse medical needs across..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with a $110 Billion Market Cap

HCA Healthcare, Inc. (HCA) has firmly established itself as a powerhouse within the medical care facilities industry, boasting an impressive market capitalization of $110.07 billion. As a leading healthcare provider..

Merck & Co., Inc. (MRK) Investor Outlook: Strong Buy Ratings and Promising Upside

As one of the prominent players in the healthcare sector, Merck & Co., Inc. (NYSE: MRK) continues to capture investor attention with its robust portfolio and strategic partnerships. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds